Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 4Lymphoma, Follicular 4Arthritis, Rheumatoid 3Pruritus 1Prostatic Neoplasms 1Plaque, Amyloid 1Bronchiolitis Obliterans Syndrome 1Bites and Stings 1Asthma 1Arthritis, Juvenile 1

Interventions

canakinumab 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Arthritis, Juvenile × Etanercept × Clear all
NCT03780959 2019-08-02

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

Amgen

Phase 2/3 Completed
69 enrolled 11 charts

Arthritis, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡